RJFSA
APYX icon

Raymond James Financial Services Advisors’s Apyx Medical APYX Stock Holding History

Raymond James Financial Services Advisors’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$107K Buy
86,609
+2,086
+2% +$2.63K ﹤0.01% 3283
2024
Q2 		$113K Sell
84,523
-200
-0.2% -$295 ﹤0.01% 3212
2024
Q1 		$115K Sell
84,723
-523,905
-86% -$1.11M ﹤0.01% 3202
2023
Q4 		$1.59M Buy
608,628
+187,350
+44% +$454K ﹤0.01% 1699
2023
Q3 		$1.35M Buy
421,278
+1,100
+0.3% +$5.13K ﹤0.01% 1745
2023
Q2 		$2.11M Buy
420,178
+27,351
+7% +$139K ﹤0.01% 1482
2023
Q1 		$1.13M Buy
392,827
+34,090
+10% +$99.5K ﹤0.01% 1830
2022
Q4 		$839K Sell
358,737
-50,373
-12% -$154K ﹤0.01% 1950
2022
Q3 		$1.84M Buy
409,110
+33,492
+9% +$240K ﹤0.01% 1464
2022
Q2 		$2.2M Buy
375,618
+73,012
+24% +$375K ﹤0.01% 1384
2022
Q1 		$1.98M Buy
302,606
+6,150
+2% +$60.6K ﹤0.01% 1496
2021
Q4 		$3.8M Buy
296,456
+8,984
+3% +$126K 0.01% 1148
2021
Q3 		$3.98M Buy
287,472
+7,069
+3% +$74.4K 0.01% 1095
2021
Q2 		$2.89M Buy
280,403
+5,185
+2% +$51.4K 0.01% 1263
2021
Q1 		$2.66M Buy
275,218
+10,663
+4% +$107K 0.01% 1235
2020
Q4 		$1.91M Buy
264,555
+7,245
+3% +$48K ﹤0.01% 1327
2020
Q3 		$1.21M Sell
257,310
-17,264
-6% -$85.5K ﹤0.01% 1434
2020
Q2 		$1.52M Buy
274,574
+16,000
+6% +$66.5K ﹤0.01% 1239
2020
Q1 		$928K Buy
258,574
+10,100
+4% +$67.8K ﹤0.01% 1240
2019
Q4 		$2.1M Sell
248,474
-10,275
-4% -$74.2K 0.01% 1144
2019
Q3 		$1.75M Buy
258,749
+13,314
+5% +$94.5K 0.01% 1177
2019
Q2 		$1.65M Buy
245,435
+18,401
+8% +$100K 0.01% 1208
2019
Q1 		$1.43M Buy
227,034
+3,300
+1% +$25.5K 0.01% 1248
2018
Q4 		$1.45M Sell
223,734
-6,600
-3% -$40K 0.01% 1071
2018
Q3 		$1.64M Buy
230,334
+82,984
+56% +$461K 0.01% 1191
2018
Q2 		$641K Buy
147,350
+46,600
+46% +$172K ﹤0.01% 1699
2018
Q1 		$299K Sell
100,750
-15,500
-13% -$39.9K ﹤0.01% 2032
2017
Q4 		$302K Buy
116,250
+6,300
+6% +$19.7K ﹤0.01% 2017
2017
Q3 		$372K Buy
109,950
+29,200
+36% +$75.4K ﹤0.01% 1900
2017
Q2 		$199K Buy
+80,750
New +$198K ﹤0.01% 2235

Other funds holding APYX

ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

Raymond James Financial Services Advisors's APYX Position: Q3 2024 in Review

Raymond James Financial Services Advisors increased its Apyx Medical (APYX) stake by 2.5% in Q3 2024, buying an estimated $2.63K and bringing the position to 86,609 shares worth $107K. The position accounts for ﹤0.01% of the portfolio, ranked #3283.

Raymond James Financial Services Advisors first reported a position in APYX in Q2 2017 and has held it in 30 quarters since. The position peaked at $3.98M in Q3 2021. 45 funds tracked by Wall St. Rank hold APYX as of Q3 2024.

  • Raymond James Financial Services Advisors held 86,609 shares of Apyx Medical worth $107K as of Q3 2024.
  • Raymond James Financial Services Advisors bought 2,086 Apyx Medical shares in Q3 2024, an estimated $2.63K.
  • Apyx Medical made up ﹤0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #3283 holding.
  • Raymond James Financial Services Advisors first reported a position in Apyx Medical in Q2 2017 and has held it in 30 quarters since.
  • Raymond James Financial Services Advisors's Apyx Medical position peaked at $3.98M in Q3 2021.
  • 45 funds tracked by Wall St. Rank held Apyx Medical as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.